{"abstract": "John C. Lechleiter, who is about to become Eli Lilly\u2019s top executive, appears to have encouraged Lilly to promote its schizophrenia drug Zyprexa for use by children and teenagers.", "web_url": "https://www.nytimes.com/2008/03/14/business/14cnd-drug.html", "snippet": "John C. Lechleiter, who is about to become Eli Lilly\u2019s top executive, appears to have encouraged Lilly to promote its schizophrenia drug Zyprexa for use by children and teenagers.", "lead_paragraph": "ANCHORAGE \u0097 John C. Lechleiter, an Eli Lilly official who is about to become the company\u2019s top executive, wrote e-mail in 2003 that appears to have encouraged Lilly to promote its schizophrenia medicine Zyprexa for a use not approved by federal drug regulators. ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Lilly E-Mail Discussed Off-Label Drug Use", "kicker": null, "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Zyprexa (Drug)", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Lilly, Eli, & Co", "rank": 2, "major": "N"}], "pub_date": "2008-03-14T04:00:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Alex Berenson", "person": [{"firstname": "Alex", "middlename": null, "lastname": "Berenson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/f8219eda-5e06-56ce-8a3b-ce3226375edd", "word_count": 1019, "uri": "nyt://article/f8219eda-5e06-56ce-8a3b-ce3226375edd"}